Skip to main content

Table 5 Incidence of adverse events during 48 hours

From: Comparing parecoxib and ketorolac as preemptive analgesia in patients undergoing posterior lumbar spinal fusion: a prospective randomized double-blinded placebo-controlled trial

Incidence of adverse events during 48 hours

Adverse events

Control No. (%)

Ketorolac No. (%)

Parecoxib No. (%)

P

Dyspepsia

2 (8.7)

2 (8.7)

0 (0)

0.541

Nausea/vomiting

10 (31.2)

12 (37.5)

11 (34.4)

0.871

Constipation

2 (6.2)

1 (3.1)

2 (6.2)

1

Dizziness

5 (15.6)

8 (25)

6 (18.8)

0.632

Pruritus

2 (6.2)

2 (6.2)

5 (15.6)

0.496